Cervical Plexus Block Combined With Translaryngeal Block for Tracheostomy

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

November 25, 2020

Study Completion Date

November 25, 2020

Conditions
Regional Anesthesia Morbidity
Interventions
PROCEDURE

ST

"After a computer-generated randomization list with a 1:1 intergroup ratio, ensuring equal distribution in the two groups, 30 opaque sealed envelopes numbered 1-30 were prepared. The patients were randomly divided into the Group with bilateral CPB with 15 ml 0.5% bupivacaine or the patients with translaryngeal block with 5 ml 2% lidocaine in addition to bilateral CPB.~Following inclusion, two research assistants, with no further involvement in the study, prepared 15mL syringes and 5 ml syringes according to the envelope's specifications. The syringes were marked with the patient's randomization number. All other investigators, staff, and patients were blinded to group allocations. Before surgery, the patients were transferred to the specified block room area monitored with 3-lead electrocardiography, pulse oximetry, and non-invasive blood pressure. All patients had two intravenous cannula lines, and then bilateral CPB block procedures were performed in awake non-sedated patients."

Trial Locations (1)

59100

Namık Kemal University, Tekirdağ

All Listed Sponsors
lead

Namik Kemal University

OTHER

NCT04697836 - Cervical Plexus Block Combined With Translaryngeal Block for Tracheostomy | Biotech Hunter | Biotech Hunter